FIELD: microbiology, virology and immunology.
SUBSTANCE: invention is intended to form the body's immunity to infections of various natures and to increase the specific activity of immunobiological drugs. An increase in the body's immunity to infections of various natures and the specific activity of immunobiological drugs is ensured by the introduction of phthalhydrazide derivative (hereinafter referred to as Abidov's adjuvant) to animals in a single dose of 150 μg / individual as an adjuvant.
EFFECT: use of the invention increases the effectiveness of specific prevention of infections, regardless of the nature of immunobiological drugs, and thereby the efforts to combat topical manageable infectious diseases of various etiologies.
4 cl, 6 tbl, 6 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
| METHOD FOR IMMUNOPROPHYLAXIS OF EXPERIMENTAL PSEUDOCHOLERA WITH ENTRAPPED ANTIGENS Burkholderia pseudomallei | 2008 |
|
RU2373955C1 |
| ADJUVANT, BASED ON LOW-MOLECULAR PEPTIDOGLYCAN OF BACTERIAL CELL WALL | 2013 |
|
RU2563354C2 |
| ANTIGEN CARRIER AND ADJUVANT | 2006 |
|
RU2311926C2 |
| METHOD OF PREPARING THE INACTIVATED VACCINE FOR PROPHYLAXIS OF VENEZUELAN ENCEPHALOMYELITIS | 1987 |
|
RU2078816C1 |
| VACCINE AGAINST AUJESZKY'S DISEASE AND SWINE ERYSIPELAS | 2009 |
|
RU2403062C1 |
| IMMUNOGENIC COMPOSITION | 2005 |
|
RU2308289C2 |
| METHOD OF PRODUCING TETRAVALENT SUBUNIT INFLUENZA VACCINE | 2019 |
|
RU2740751C1 |
| IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
| ADJUVANT FOR ANTI-VIRAL VACCINES | 2017 |
|
RU2676266C2 |
